Adenovirus infection and anti-GBM disease (Goodpasture syndrome): a clinical case
https://doi.org/10.22625/2072-6732-2025-17-1-114-119
Abstract
Goodpasture’s syndrome, an autoimmune disease resulting from the appearance of antibodies to the glomerular basement membrane, is a rare and potentially dangerous complication of infectious diseases such as influenza, new coronavirus infection, adenovirus infection. The course may be atypical and manifest as a severe form of viral disease complicated by acute respiratory distress syndrome and sepsis against the background of an accompanying bacterial infection. The necessary diagnostic methods may be unavailable or performed with a significant delay if biological material is sent to third-party organizations. Timely diagnosis and initiation of specific treatment can reduce mortality by almost half. The article presents a clinical case of a patient with Goodpasture syndrome who was at the clinic of infectious diseases S.M. Kirov Military Medical Academy with acute respiratory viral infection complicated by polysegmental pneumonia.
About the Authors
G. E. LysenkoRussian Federation
Saint-Petersburg
Competing Interests:
None
K. V. Kozlov
Russian Federation
Saint-Petersburg
Competing Interests:
None
E. V. Kryukov
Russian Federation
Saint-Petersburg
Competing Interests:
None
D. M. Shakhmanov
Russian Federation
Saint-Petersburg
Competing Interests:
None
V. G. Arsentiev
Russian Federation
Saint-Petersburg
Competing Interests:
None
R. E. Lahin
Russian Federation
Saint-Petersburg
Competing Interests:
None
A. V. Lyubimov
Russian Federation
Saint-Petersburg
Competing Interests:
None
A. A. Selkina
Russian Federation
Saint-Petersburg
Competing Interests:
None
References
1. Fouka E., Drakopanagiotakis F., Steiropoulos P. Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome // International Journal of Molecular Sciences. 2024. Vol. 72, N 25. P. 240-249. DOI: 10.1016/j.matbio.2018.05.004
2. Pedchenko V., Kitching A. R., Hudson B. G. Goodpasture’s autoimmune disease — A collagen IV disorder // Matrix Biology. 2018. Vol. 71-72, P. 240–249. DOI: 10.1016/j.matbio.2018.05.004
3. Rovin B., Adler S. et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases // Kidney International. 2021. Vol. 4, Т.100. P. 1–276. DOI: 10.1016/j.kint.2021.05.015
4. Reggiani F., L’Imperio V., Calatroni M., Pagni, F. Good-pasture syndrome and anti-glomerular basement membrane disease // Clinical and experimental rheumatology. 2023. Vol. 41, N 5. P. 964–974. https://doi.org/10.55563/clinexprheumatol/tep3k5
5. Asim M., Akhtar, M. Epidemiology, Impact, and Management Strategies of Anti-Glomerular Basement Membrane Disease // International journal of nephrology and renovascular disease. 2022. Vol. 15, P.129–138. DOI: 10.2147/IJNRD.S326427
6. Asim M., Akhtar, M. Epidemiology, Impact, and Management Strategies of Anti-Glomerular Basement Membrane Disease // International journal of nephrology and renovascular disease. 2022. Vol. 15, P.129–138. DOI: 10.2147/IJNRD.S326427
7. Hellmark T., Segelmark M. Diagnosis and classification of Goodpasture’s disease (anti-GBM) // Journal of Autoimmunity. 2014. Vol. 48–49, P. 108–112. DOI: 10.1016/j.jaut.2014.01.024
8. McAdoo S. P., Pusey C. D. Anti-glomerular basement membrane disease // Clinical Journal of the American Society of Nephrology. 2017. Vol. 7, T. 12. P. 1162–1172. DOI: 10.2215/CJN.01380217
9. Schwartz J. Padmanabhan A. et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue // Journal of Clinical Apheresis. 2016. Vol. 3, Т. 31. P. 149–338. DOI: 10.1002/jca.21470
10. Jain R., Dgheim H., Bomback A. S. Rituximab for Anti-Glomerular Basement Membrane Disease // Kidney international reports. 2018. Vol. 4, Т. 4. P. 614–618. DOI: 10.1016/j.ekir.2018.12.002
11. Matthay M. A., Arabi, Y. et al. A New Global Definition of Acute Respiratory Distress Syndrome // American Journal of Respiratory and Critical Care Medicine. 2024. Vol. 1, Т.4. P. 37–47. DOI: 10.1164/rccm.202303-0558WS
12. Zaitsev A.A., Makarevich A.M., Patsenko M.B., Sinopalnikov A.I., Sergoventsev A.A., Kryukov E.V. Diagnosis and treatment of community-acquired pneumonia in military personnel (Guidelines). Clinical Medicine (Russian Journal). 2024;102(3):212-229. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-11-212-229
Review
For citations:
Lysenko G.E., Kozlov K.V., Kryukov E.V., Shakhmanov D.M., Arsentiev V.G., Lahin R.E., Lyubimov A.V., Selkina A.A. Adenovirus infection and anti-GBM disease (Goodpasture syndrome): a clinical case. Journal Infectology. 2025;17(1):114-119. (In Russ.) https://doi.org/10.22625/2072-6732-2025-17-1-114-119